Christopher Gordon, MD
Sports Medicine · Provo, UTNPI 1922232867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Grifols USA, LLC at 31.9% of the total. 2025 is the largest year on record at $296, 2.3 times the $127 reported in 2020.
Across 65 payments — averaging $21.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$442
- Takeda Pharmaceuticals U.S.A., Inc.$234
- Boehringer Ingelheim$154
- Kaleo, Inc.$150
- Novartis$110
- Teva Pharmaceuticals USA, Inc.$85
- plus $211 from 7 others
What the payments were for
- Food & beverage$1,387100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 19 | $442 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $234 |
| Boehringer Ingelheim | 8 | $154 |
| Kaleo, Inc. | 7 | $150 |
| Novartis | 6 | $110 |
| Teva Pharmaceuticals USA, Inc. | 6 | $85 |
| Trice Medical, Inc. | 1 | $76 |
| GSK | 3 | $44 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Organon | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Merck | 1 | $16 |
How this compares
$1,387 in reported general payments places this provider in the 65th percentile of 83 sports medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 33 | $538 |
| Tizanidine Hcl | 56 | $434 |
| Flunisolide | 11 | $337 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Provo
- Trevor SheltonProvo$43K
- Karl WeenigProvo$1K
- Michael NeilsonProvo$425
- Eric RobinsonProvo$308
- Thomas RosenbergPark City$5.5M
- Charles BeckDraper$157K
- Colby BarberSt George$61K
- Philip DavidsonPark City$60K
- Sean DavisOgden$60K
- Gary EdwardsLehi$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.